Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 12 years old or older and have been diagnosed with asthma by a doctor
- Your doctor has prescribed you a specific inhaled asthma medication called Atectura (indacaterol/mometasone), used with a Breezhaler device, at one of the approved doses
- You are willing to sign a consent form agreeing to how your data will be collected and used (if you are under 18, a parent or legal guardian must also sign)
Who may not be able to join:
- You have had an allergic reaction to this medication or any of its ingredients in the past
- You have a hereditary condition that causes problems processing lactose or galactose (such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption), since this medication contains lactose
- You are currently experiencing sudden or severe asthma symptoms that require you to use a quick-relief (rescue) inhaler
- You are already taking part in another clinical trial that involves a medical treatment or intervention
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Novartis Pharmaceuticals, Novartis Pharmaceuticals
Phone: +41613241111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of adverse events and serious adverse events; Incidence of unexpected adverse events and unexpected serious adverse events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.